Dr Mrinalini Mudkanna, MD | |
9055 Springbrook Dr Nw, Coon Rapids, MN 55433-5841 | |
(763) 780-9155 | |
Not Available |
Full Name | Dr Mrinalini Mudkanna |
---|---|
Gender | Female |
Speciality | Geriatric Medicine |
Experience | 32 Years |
Location | 9055 Springbrook Dr Nw, Coon Rapids, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245331800 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 49094 (Minnesota) | Primary |
207RG0300X | Internal Medicine - Geriatric Medicine | 49094 (Minnesota) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Allina Health Home Health | Saint paul, MN | Home health agency |
Interim Healthcare Of The Twin Cities | Roseville, MN | Home health agency |
Lifesprk Home Health | Saint louis park, MN | Home health agency |
Allina Health Hospice & Palliative Care | Saint paul, MN | Hospice |
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Mercy Hospital | Coon rapids, MN | Hospital |
Cambridge Medical Center | Cambridge, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allina Health System | 4587573613 | 3071 |
News Archive
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
Infants show distinct, consistent patterns of brain activity in response to painful vaccinations, reports a study in the February issue of PAIN, the official publication of the International Association for the Study of Pain.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).
Milk from organic farms has a lower concentration of elements like zinc, iodine and selenium than milk produced by conventional farming methods.
› Verified 4 days ago
Entity Name | Allina Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
Infants show distinct, consistent patterns of brain activity in response to painful vaccinations, reports a study in the February issue of PAIN, the official publication of the International Association for the Study of Pain.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).
Milk from organic farms has a lower concentration of elements like zinc, iodine and selenium than milk produced by conventional farming methods.
› Verified 4 days ago
Entity Name | Allina Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
Infants show distinct, consistent patterns of brain activity in response to painful vaccinations, reports a study in the February issue of PAIN, the official publication of the International Association for the Study of Pain.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).
Milk from organic farms has a lower concentration of elements like zinc, iodine and selenium than milk produced by conventional farming methods.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Mrinalini Mudkanna, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Dr Mrinalini Mudkanna, MD 9055 Springbrook Dr Nw, Coon Rapids, MN 55433-5841 Ph: (763) 780-9155 |
News Archive
KalVista Pharmaceuticals, a research-led pharmaceutical company, today announced it has raised $33 million in a Series B financing to support its research and clinical development programs. KalVista will use the funds to advance its proprietary portfolio of plasma kallikrein inhibitors for treating diabetic macular edema (DME) and hereditary angioedema (HAE).
Infants show distinct, consistent patterns of brain activity in response to painful vaccinations, reports a study in the February issue of PAIN, the official publication of the International Association for the Study of Pain.
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI).
Milk from organic farms has a lower concentration of elements like zinc, iodine and selenium than milk produced by conventional farming methods.
› Verified 4 days ago
Dr. Oladepo Collins Fasoranti, MBBS Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11475 Robinson Drive Nw - Mailstop 32600a, Healthpartners Coon Rapids Clinic, Coon Rapids, MN 55433 Phone: 763-587-9000 Fax: 763-587-9130 | |
Mark H. Brakke, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Kelly Ann Mcteague, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Alena V Marozava, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Dr. Matthew Varner, M.D., M.P.H. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Emily Nicole Hicke, PA Family Medicine Medicare: Medicare Enrolled Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Jaqueline Sherry Olczak, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 |